---
title: "Cinda Securities: YUYUE MEDICAL's business is expected to maintain steady growth, initiating a \"Buy\" rating"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229878499.md"
description: "Cinda Securities released a research report, believing that YUYUE MEDICAL will see an increase in demand for home health management against the backdrop of an aging population, leading to an expansion of the home medical device market. As a leading manufacturer, YUYUE MEDICAL has a rich product line, enhanced brand influence, and is expected to increase its market share with stable business growth. The company's brand value has significantly improved, customer loyalty has strengthened, and it has been given a \"Buy\" rating for its initial coverage"
datetime: "2025-02-27T08:49:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229878499.md)
  - [en](https://longbridge.com/en/news/229878499.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229878499.md)
generator: "portal-rs"
---

# Cinda Securities: YUYUE MEDICAL's business is expected to maintain steady growth, initiating a "Buy" rating

According to a research report by Xinda Securities, it is believed that against the backdrop of an aging population, the demand for health management and family wellness among residents is increasing, and the market size for home medical device products is expected to gradually expand. YUYUE MEDICAL, as a leading domestic manufacturer of home medical devices, is expected to continuously increase its market share and maintain steady growth in its business as its product pipeline gradually enriches and brand influence continues to strengthen. In terms of brand power, relying on the continuous improvement of YUYUE's product strength and effective brand communication, as well as the outstanding performance of its products in frontline medical settings both domestically and internationally, the company's brand value and advantages have significantly improved, customer loyalty has further strengthened, and its leading position has been solidified. This is the first coverage, giving a "Buy" investment rating

### Related Stocks

- [002223.CN](https://longbridge.com/en/quote/002223.CN.md)
- [601059.CN](https://longbridge.com/en/quote/601059.CN.md)

## Related News & Research

- [Jiangsu Yuyue Medical Equipment & Supply: Net profit fell 29.92% year-over-year, but overseas and CGM sales grew sharply](https://longbridge.com/en/news/296602713.md)
- [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md)
- [Scott Bessent Brings His Hedge Fund Playbook To Treasury. The Bond Market Is Fighting Back](https://longbridge.com/en/news/296520391.md)
- [The rise in interest rates hit a 'raw nerve' at the White House. Bessent's plan has analysts on edge.](https://longbridge.com/en/news/296517751.md)
- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**